Dr. Alexandra Perez is a geriatric pharmacist specializing in chronic disease state management. She has experience collaborating with healthcare providers in primary care clinics, optimizing medication regimens. She also has experience in clinical informatics partnering with pharmaceutical companies to help them leverage real world clinical data to perform research studies.\n
Education\n
\n
University of Florida, MBA, PharmD\n
University of Miami, BS\n\n
Certifications\n
\n
Licensed Pharmacist\n
Board Certified Geriatric Pharmacist (BCGP)\n
Pharmacist Teaching Certificate\n\n
Professional Accomplishments\n
\n
Participated on Pharmaceutical Industry Advisory Board\n
Guest lecturer at University of Florida and University of South Florida Colleges of Pharmacy\n\n
SSRIs are a type of antidepressant. Learn about these commonly prescribed drugs, including side effects, how they work, and their pros and cons.
If youâre currently dealing with a mental health condition like depression, you are not alone.
According to the National Alliance on Mental Illness (NAMI), in the United States nearly 1 in 5 adults and 1 in 6 youth (ages 6 to 17 years) experience mental illness each year.
Selective serotonin reuptake inhibitors (SSRIs) are a class of medications most often used to treat depression as well as a few other mental health conditions.
SSRIs are a first-line treatment for depression and a few other mental health conditions because they tend to be effective for the general population and have fewer side effects.
The main way that SSRIs help people manage conditions like depression is by increasing serotonin in the brain. While thereâs still not a definitive answer, the consensus is that depleted serotonin plays a key role in depression.
There are several off-label uses for SSRIs too. âOff-labelâ means a medication is prescribed to treat an issue that it was not specifically developed for. In the case of SSRIs, off-label uses include:
Serotonin is one of many brain chemicals that transmit messages between brain cells. It has been called the âfeel-good chemicalâ because it causes a relaxed state of well-being. Normally, serotonin circulates in the brain and then absorbs into the bloodstream.
Depression is linked with low levels of serotonin (as well as low levels of dopamine, norepinephrine, and other brain chemicals).
SSRIs work by preventing your blood from absorbing some of the serotonin from your brain. This leaves a higher level of serotonin in the brain. Increased serotonin can help relieve depression.
SSRIs donât cause the body to make more serotonin, however. They simply help the body use what it has more effectively.
While SSRIs are fairly similar in terms of their effectiveness, they do vary slightly in what theyâre used to treat, their side effects, their dosage, and other factors.
Because SSRIs have very little effect on other neurotransmitters in the brain like dopamine and norepinephrine, there are fewer reported side effects than tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs), which are other classes of antidepressants.
Still, side effects can still be possible with SSRIs. The most common ones include:
Itâs also important to note that the Food and Drug Administration (FDA) has warned that antidepressants like SSRIs may increase the risk of suicidality among children and young adults.
However, because depression can also lead to an increase in suicidal thoughts, this side effect should be discussed with your doctor so you can weigh the pros and cons of starting the medication.
âSelective serotonin reuptake inhibitors are very safe drugs, generally speaking,â says Danny Carlat, MD, associate clinical professor of psychiatry at Tufts University School of Medicine.
âWhile there are some pretty minor side effects, it would be very hard for people to do any damage to themselves by taking an SSRI,â he says.
That said, certain people should be cautious about using an SSRI. These include children and pregnant people.
For children
Because thereâs less research about children and SSRIs than adults and SSRIs, younger people should be monitored for changes in mood and behavior.
For pregnant people
SSRIs may increase the risk of certain fetal developmental issues, especially heart and lung problems.
Doctors and moms-to-be must compare the risks of SSRI treatment to the risks of untreated depression. Depression without treatment can also have a negative impact on a pregnancy. For instance, mothers with depression may not seek the prenatal care they need.
Some pregnant people may opt to switch their SSRI to reduce their risk of side effects while still treating their depression. This is because different SSRIs have different side effects.
For instance, paroxetine (Paxil) has been linked with fetal heart issues in newborns.
If you take paroxetine and become pregnant, your doctor may suggest you switch to fluoxetine (Prozac) or citalopram (Celexa). These SSRIs arenât linked with such serious side effects.
General risks
Make sure to tell your doctor about all your other underlying conditions. People with other health conditions such as epilepsy, diabetes, and kidney disease may have to be monitored more closely when taking SSRIs.
Certain SSRIs may also react with other medications youâre taking, as well as with certain supplements (such as St. Johnâs wort).
As with your underlying conditions, make sure to let your doctor know about any over-the-counter medications or supplements you take regularly.
Antidepressants like SSRIs are one method to help ease the symptoms of depression, but theyâre typically just part of a treatment plan.
Your doctor may also recommend therapy, and if you chose to go, your therapist may have advice and methods to help you, depending on the severity of your symptoms and your personal history.
Some questions to ask yourself when youâre considering SSRIs include:
Do you feel as though your mental health condition is disrupting your life?
Do you feel less pleasure when it comes to the things you used to enjoy?
Do you consistently have trouble concentrating?
Have you taken antidepressants before? If so, did they help? Were the side effects severe?
If you think you may have depression but arenât sure, there are several screening questionnaires that can be helpful. Discussing the results with your doctor is a great first step.
While some doctors advise against drinking alcohol while taking SSRIs, many people find it difficult to completely stop their alcohol consumption during treatment.
A key reason doctors advise against drinking is because both SSRIs and alcohol may influence your mood, and may also make you drowsy and less alert.
Itâs also possible that consuming too much alcohol regularly could disrupt the effectiveness of your SSRIs.
The consensus seems to be: If you want to drink while taking SSRIs, itâs important to drink in moderation. That means approximately one drink a day for most people, which translates into:
12 oz. of beer
5 oz. of wine
1 oz. of liquor
Talk with your doctor and see what their advice is around moderate alcohol consumption and SSRIs.
If you think an SSRI might be a good option for you, make an appointment to talk with a doctor about your symptoms. They will review your health history with you and help decide whether an SSRI is a good fit.
Some questions you might want to ask your doctor include:
Am I at high risk of side effects from an SSRI?
Do I take any medications that might interact with an SSRI?
It may take a little bit of time to find the right SSRI, or the right antidepressant in general, that works for you. The good news is that many people find SSRIs to be helpful in treating their symptoms, allowing them to get back to a more fulfilling, happy life.
How we reviewed this article:
Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.
Bérard A, et al. (2016). The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: A systematic review and meta‐analysis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799922/
Locher C, et al. (2017). Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667359/